lobbying_activities: 1405111

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1405111	0b38c9dc-2823-4137-9aa0-2e81237feec1	Q2	MASSACHUSETTS MEDICAL SOCIETY	23975	MASSACHUSETTS MEDICAL SOCIETY	2013	second_quarter	PHA	HR 1285, S 621 - Safe Prescribing Act of 2013, to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug Drug Diversion issues including, reauthorization of the NASPER, appropriations for the Substance Abuse & Mental health	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE		60000	0	0	2013-07-11T14:58:10-04:00